what is compounded semaglutide and tirzepatide Program: Results, Timeline & Comparison GLP-1² Advanced Weight Loss Therapy

WATER/AQUA/EAU, GLYCERIN, NIACINAMIDE, CAPRYLIC/CAPRIC TRIGLYCERIDE, GLYCERETH-26, PHENYL TRIMETHICONE, 1,2-HEXANEDIOL, BEHENYL ALCOHOL, POLYMETHYLSILSESQUIOXANE, CHLORELLA VULGARIS EXTRACT, GLUCOSE, CARBOMER, BUTYLENE GLYCOL, CAPRYLYL GLYCOL, FRUCTOOLIGOSACCHARIDES, FRUCTOSE, HIPPOPHAE RHAMNOIDES OIL, TROMETHAMINE, ETHYLHEXYLGLYCERIN, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, CITRUS JUNOS PEEL OIL, TOCOPHERYL ACETATE, DISODIUM EDTA, ECLIPTA PROSTRATA EXTRACT, ECLIPTA PROSTRATA LEAF EXTRACT, CITRUS JUNOS SEED OIL, MORINGA OLEIFERA SEED OIL, HYDROGENATED LECITHIN, CHOLESTEROL, PEG-800, ASCORBIC ACID, TOCOPHEROL, POLYSORBATE 20, CERAMIDE NP, LINOLEIC ACID, RETINOL, CITRUS JUNOS FRUIT OIL, BIOFLAVONOIDS, SH-OLIGOPEPTIDE-1, SH-POLYPEPTIDE-1, SH-OLIGOPEPTIDE-2, SH-POLYPEPTIDE-22, SH-POLYPEPTIDE-45, SH-POLYPEPTIDE-8, SH-POLYPEPTIDE-9

R.El-SeragH

Tirzepatide activates both GLP-1 and GIP receptors, producing stronger appetite suppression and greater average weight loss in clinical trials

This rise has important implications for public health spending and chronic disease burden